Abin Sajan BS, Soombal Zahid DO, Jordan Stumph MD, Daniel Griepp BE, Sami Saba MD, Nazish Ilyas MD and Isabel M. Mc Farlane MD. A Rare Case of HIV-Induced Inflammatory Demyelinating Polyneuropathy.
. 2019; 7(1):5-8. doi: 10.12691/AJMCR-7-1-2
human immunodeficiency virus, acute inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, intravenous immunoglobulin, peripheral neuropathy, chronic inflammatory demyelinating polyneuropathy, highly active antiretroviral therapy
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Arts, E.J. and D.J. Hazuda, HIV-1 antiretroviral drug therapy. Cold Spring Harbor perspectives in medicine, 2012. 2(4): p. a007161-a007161. |
|
[2] | Bilgrami, M. and P. O'Keefe, Neurologic diseases in HIV-infected patients. Handb Clin Neurol, 2014. 121: p. 1321-44. |
|
[3] | Gelman, B.B., Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered. Current HIV/AIDS reports, 2015. 12(2): p. 272-279. |
|
[4] | Kolson, D., Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy. Topics in antiviral medicine, 2017. 25(3): p. 97-101. |
|
[5] | Saylor, D., et al., HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nature reviews. Neurology, 2016. 12(5): p. 309-309. |
|
[6] | Wulff, E.A., A.K. Wang, and D.M. Simpson, HIV-Associated Peripheral Neuropathy. Drugs, 2000. 59(6): p. 1251-1260. |
|
[7] | Moodley, K., P.L.A. Bill, and V.B. Patel, A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients. Neurology(R) neuroimmunology & neuroinflammation, 2016. 4(2): p. e315-e315. |
|
[8] | Shepherd, S.J., et al., HIV positive patient with GBS-like syndrome. JMM Case Rep, 2017. 4(8): p. e005107. |
|
[9] | Hagberg, L., et al., Guillain-Barré Syndrome as an Early Manifestation of HIV Central Nervous System Infection. Scandinavian Journal of Infectious Diseases, 1986. 18(6): p. 591-592. |
|
[10] | Parry, G.J., Peripheral neuropathies associated with human immunodeficiency virus infection. Annals of Neurology, 1988. 23(S1): p. S49-S53. |
|
[11] | Willison, H.J., B.C. Jacobs, and P.A. van Doorn, Guillain-Barre syndrome. The Lancet, 2016. 388(10045): p. 717-727. |
|
[12] | Dimachkie, M.M. and R.J. Barohn, Guillain-Barré syndrome and variants. Neurologic clinics, 2013. 31(2): p. 491-510. |
|
[13] | Pontali, E., et al., Guillain-Barre Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report. Case Reports in Infectious Diseases, 2011. 2011: p. 4. |
|
[14] | Sloan, D.J., et al., Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report. J Med Case Rep, 2008. 2: p. 370. |
|
[15] | Petratos, S., et al., Antibodies against peripheral myelin glycolipids in people with HIV infection. Immunol Cell Biol, 1998. 76(6): p. 535-41. |
|
[16] | Rosca, E.C., O. Rosca, and M. Simu, Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barré syndrome. International Immunopharmacology, 2015. 29(2): p. 964-965. |
|
[17] | Köller, H., et al., Chronic Inflammatory Demyelinating Polyneuropathy. New England Journal of Medicine, 2005. 352(13): p. 1343-1356. |
|
[18] | Mathey, E.K., et al., Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. Journal of neurology, neurosurgery, and psychiatry, 2015. 86(9): p. 973-985. |
|
[19] | Ramos Ttito, A.P., et al., Chronic inflammatory demyelinating polyneuropathy associated with HIV and Neurosyphilis coinfection. Journal of the Neurological Sciences, 2017. 381: p. 830. |
|
[20] | Hiraga, A., et al., Recovery patterns and long term prognosis for axonal Guillain–Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 2005. 76(5): p. 719. |
|
[21] | Meena, A.K., S.V. Khadilkar, and J.M.K. Murthy, Treatment guidelines for Guillain-Barré Syndrome. Annals of Indian Academy of Neurology, 2011. 14(Suppl 1): p. S73-S81. |
|
[22] | Harms, M., Inpatient management of guillain-barré syndrome. The Neurohospitalist, 2011. 1(2): p. 78-84. |
|
[23] | Brannagan, T.H., 3rd and Y. Zhou, HIV-associated Guillain-Barre syndrome. J Neurol Sci, 2003. 208(1-2): p. 39-42. |
|
[24] | Kuitwaard, K., et al., Recurrent Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry, 2009. 80(1): p. 56-9. |
|
[25] | Makela, P., et al., Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV. J Infect, 2002. 44(1): p. 47-9. |
|